Gene symbol: Igf1

Also known as: IGF

Organism: Rattus norvegicus

Summary: Enables protein serine/threonine kinase activator activity; signaling receptor binding activity; and steroid binding activity. Involved in several processes, including cellular response to hormone stimulus; negative regulation of cell death; and positive regulation of cell differentiation. Located in several cellular components, including interstitial matrix; neuronal cell body; and platelet alpha granule. Used to study brain ischemia; diabetic neuropathy; and hypertension. Biomarker of several diseases, including alcoholic neuropathy; artery disease (multiple); congenital diaphragmatic hernia; folic acid deficiency anemia; and hypothyroidism (multiple). Human ortholog(s) of this gene implicated in several diseases, including acne; brain ischemia; diabetes mellitus (multiple); myopia; and neurodegenerative disease (multiple). Orthologous to human IGF1 (insulin like growth factor 1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24482 Ensembl:ENSRNOG00000004517 AllianceGenome:RGD:2868


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000165 MAPK cascade
Process GO:0001501 Skeletal system development
Process GO:0001503 Ossification
Process GO:0001558 Regulation of cell growth
Process GO:0001649 Osteoblast differentiation
Process GO:0001655 Urogenital system development
Process GO:0001666 Response to hypoxia
Process GO:0001678 Cellular glucose homeostasis
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001818 Negative regulation of cytokine production
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001936 Regulation of endothelial cell proliferation
Process GO:0001938 Positive regulation of endothelial cell proliferation
Process GO:0001944 Vasculature development
Process GO:0001974 Blood vessel remodeling
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0002682 Regulation of immune system process
Process GO:0002683 Negative regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002696 Positive regulation of leukocyte activation
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003205 Cardiac chamber development
Process GO:0003230 Cardiac atrium development
Process GO:0005979 Regulation of glycogen biosynthetic process
Process GO:0006029 Proteoglycan metabolic process
Process GO:0006109 Regulation of carbohydrate metabolic process
Process GO:0006110 Regulation of glycolytic process
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006417 Regulation of translation
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006915 Apoptotic process
Process GO:0006950 Response to stress
Process GO:0007088 Regulation of mitotic nuclear division
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007169 Transmembrane receptor protein tyrosine kinase signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007346 Regulation of mitotic cell cycle
Process GO:0007399 Nervous system development
Process GO:0007423 Sensory organ development
Process GO:0007507 Heart development
Process GO:0007565 Female pregnancy
Process GO:0007568 Aging
Process GO:0007584 Response to nutrient
Process GO:0007600 Sensory perception
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0007613 Memory
Process GO:0007623 Circadian rhythm
Process GO:0008152 Metabolic process
Process GO:0008219 Cell death
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009058 Biosynthetic process
Process GO:0009059 Macromolecule biosynthetic process
Process GO:0009100 Glycoprotein metabolic process
Process GO:0009101 Glycoprotein biosynthetic process
Process GO:0009266 Response to temperature stimulus
Process GO:0009408 Response to heat
Process GO:0009581 Detection of external stimulus
Process GO:0009582 Detection of abiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009611 Response to wounding
Process GO:0009612 Response to mechanical stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009743 Response to carbohydrate
Process GO:0009746 Response to hexose
Process GO:0009749 Response to glucose
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010001 Glial cell differentiation
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010466 Negative regulation of peptidase activity
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010559 Regulation of glycoprotein biosynthetic process
Process GO:0010560 Positive regulation of glycoprotein biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010564 Regulation of cell cycle process
Process GO:0010594 Regulation of endothelial cell migration
Process GO:0010595 Positive regulation of endothelial cell migration
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010608 Post-transcriptional regulation of gene expression
Process GO:0010611 Regulation of cardiac muscle hypertrophy
Process GO:0010613 Positive regulation of cardiac muscle hypertrophy
Process GO:0010628 Positive regulation of gene expression
Process GO:0010629 Negative regulation of gene expression
Process GO:0010632 Regulation of epithelial cell migration
Process GO:0010634 Positive regulation of epithelial cell migration
Process GO:0010638 Positive regulation of organelle organization
Process GO:0010639 Negative regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010656 Negative regulation of muscle cell apoptotic process
Process GO:0010660 Regulation of muscle cell apoptotic process
Process GO:0010675 Regulation of cellular carbohydrate metabolic process
Process GO:0010676 Positive regulation of cellular carbohydrate metabolic process
Process GO:0010720 Positive regulation of cell development
Process GO:0010721 Negative regulation of cell development
Process GO:0010817 Regulation of hormone levels
Process GO:0010821 Regulation of mitochondrion organization
Process GO:0010823 Negative regulation of mitochondrion organization
Process GO:0010827 Regulation of glucose transmembrane transport
Process GO:0010828 Positive regulation of glucose transmembrane transport
Process GO:0010893 Positive regulation of steroid biosynthetic process
Process GO:0010906 Regulation of glucose metabolic process
Process GO:0010907 Positive regulation of glucose metabolic process
Process GO:0010941 Regulation of cell death
Process GO:0010951 Negative regulation of endopeptidase activity
Process GO:0010959 Regulation of metal ion transport
Process GO:0010962 Regulation of glucan biosynthetic process
Process GO:0012501 Programmed cell death
Process GO:0014013 Regulation of gliogenesis
Process GO:0014015 Positive regulation of gliogenesis
Process GO:0014065 Phosphatidylinositol 3-kinase signaling
Process GO:0014066 Regulation of phosphatidylinositol 3-kinase signaling
Process GO:0014068 Positive regulation of phosphatidylinositol 3-kinase signaling
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0014742 Positive regulation of muscle hypertrophy
Process GO:0014743 Regulation of muscle hypertrophy
Process GO:0014823 Response to activity
Process GO:0014834 Skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
Process GO:0014896 Muscle hypertrophy
Process GO:0014902 Myotube differentiation
Process GO:0014904 Myotube cell development
Process GO:0014910 Regulation of smooth muscle cell migration
Process GO:0014911 Positive regulation of smooth muscle cell migration
Process GO:0019216 Regulation of lipid metabolic process
Process GO:0019218 Regulation of steroid metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0021700 Developmental maturation
Process GO:0021936 Regulation of cerebellar granule cell precursor proliferation
Process GO:0021940 Positive regulation of cerebellar granule cell precursor proliferation
Process GO:0022008 Neurogenesis
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022409 Positive regulation of cell-cell adhesion
Process GO:0022414 Reproductive process
Process GO:0022612 Gland morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030104 Water homeostasis
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030162 Regulation of proteolysis
Process GO:0030166 Proteoglycan biosynthetic process
Process GO:0030282 Bone mineralization
Process GO:0030307 Positive regulation of cell growth
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030850 Prostate gland development
Process GO:0030855 Epithelial cell differentiation
Process GO:0030879 Mammary gland development
Process GO:0031000 Response to caffeine
Process GO:0031016 Pancreas development
Process GO:0031017 Exocrine pancreas development
Process GO:0031099 Regeneration
Process GO:0031214 Biomineral tissue development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031641 Regulation of myelination
Process GO:0031643 Positive regulation of myelination
Process GO:0031644 Regulation of nervous system process
Process GO:0031646 Positive regulation of nervous system process
Process GO:0031647 Regulation of protein stability
Process GO:0031667 Response to nutrient levels
Process GO:0031960 Response to corticosteroid
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032147 Activation of protein kinase activity
Process GO:0032148 Activation of protein kinase B activity
Process GO:0032350 Regulation of hormone metabolic process
Process GO:0032352 Positive regulation of hormone metabolic process
Process GO:0032355 Response to estradiol
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032570 Response to progesterone
Process GO:0032651 Regulation of interleukin-1 beta production
Process GO:0032652 Regulation of interleukin-1 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032691 Negative regulation of interleukin-1 beta production
Process GO:0032692 Negative regulation of interleukin-1 production
Process GO:0032720 Negative regulation of tumor necrosis factor production
Process GO:0032868 Response to insulin
Process GO:0032869 Cellular response to insulin stimulus
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032878 Regulation of establishment or maintenance of cell polarity
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032881 Regulation of polysaccharide metabolic process
Process GO:0032885 Regulation of polysaccharide biosynthetic process
Process GO:0032944 Regulation of mononuclear cell proliferation
Process GO:0032946 Positive regulation of mononuclear cell proliferation
Process GO:0033043 Regulation of organelle organization
Process GO:0033143 Regulation of intracellular steroid hormone receptor signaling pathway
Process GO:0033144 Negative regulation of intracellular steroid hormone receptor signaling pathway
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034248 Regulation of cellular amide metabolic process
Process GO:0034249 Negative regulation of cellular amide metabolic process
Process GO:0034284 Response to monosaccharide
Process GO:0034350 Regulation of glial cell apoptotic process
Process GO:0034351 Negative regulation of glial cell apoptotic process
Process GO:0034391 Regulation of smooth muscle cell apoptotic process
Process GO:0034392 Negative regulation of smooth muscle cell apoptotic process
Process GO:0034645 Cellular macromolecule biosynthetic process
Process GO:0034762 Regulation of transmembrane transport
Process GO:0034764 Positive regulation of transmembrane transport
Process GO:0035094 Response to nicotine
Process GO:0035239 Tube morphogenesis
Process GO:0035264 Multicellular organism growth
Process GO:0035265 Organ growth
Process GO:0035272 Exocrine system development
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0035630 Bone mineralization involved in bone maturation
Process GO:0036293 Response to decreased oxygen levels
Process GO:0038034 Signal transduction in absence of ligand
Process GO:0040007 Growth
Process GO:0040008 Regulation of growth
Process GO:0040012 Regulation of locomotion
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0040017 Positive regulation of locomotion
Process GO:0042060 Wound healing
Process GO:0042063 Gliogenesis
Process GO:0042102 Positive regulation of T cell proliferation
Process GO:0042104 Positive regulation of activated T cell proliferation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042129 Regulation of T cell proliferation
Process GO:0042221 Response to chemical
Process GO:0042246 Tissue regeneration
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042509 Regulation of tyrosine phosphorylation of STAT protein
Process GO:0042531 Positive regulation of tyrosine phosphorylation of STAT protein
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0042594 Response to starvation
Process GO:0042692 Muscle cell differentiation
Process GO:0042981 Regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043154 Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043255 Regulation of carbohydrate biosynthetic process
Process GO:0043269 Regulation of ion transport
Process GO:0043279 Response to alkaloid
Process GO:0043281 Regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043388 Positive regulation of DNA binding
Process GO:0043403 Skeletal muscle tissue regeneration
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043409 Negative regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043434 Response to peptide hormone
Process GO:0043467 Regulation of generation of precursor metabolites and energy
Process GO:0043470 Regulation of carbohydrate catabolic process
Process GO:0043491 Protein kinase B signaling
Process GO:0043502 Regulation of muscle adaptation
Process GO:0043535 Regulation of blood vessel endothelial cell migration
Process GO:0043536 Positive regulation of blood vessel endothelial cell migration
Process GO:0043549 Regulation of kinase activity
Process GO:0043567 Regulation of insulin-like growth factor receptor signaling pathway
Process GO:0043568 Positive regulation of insulin-like growth factor receptor signaling pathway
Process GO:0043583 Ear development
Process GO:0043931 Ossification involved in bone maturation
Process GO:0044057 Regulation of system process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044260 Cellular macromolecule metabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0044703 Multi-organism reproductive process
Process GO:0044706 Multi-multicellular organism process
Process GO:0045428 Regulation of nitric oxide biosynthetic process
Process GO:0045445 Myoblast differentiation
Process GO:0045471 Response to ethanol
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045598 Regulation of fat cell differentiation
Process GO:0045600 Positive regulation of fat cell differentiation
Process GO:0045667 Regulation of osteoblast differentiation
Process GO:0045669 Positive regulation of osteoblast differentiation
Process GO:0045725 Positive regulation of glycogen biosynthetic process
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045787 Positive regulation of cell cycle
Process GO:0045821 Positive regulation of glycolytic process
Process GO:0045834 Positive regulation of lipid metabolic process
Process GO:0045840 Positive regulation of mitotic nuclear division
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045861 Negative regulation of proteolysis
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045913 Positive regulation of carbohydrate metabolic process
Process GO:0045927 Positive regulation of growth
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045940 Positive regulation of steroid metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0046006 Regulation of activated T cell proliferation
Process GO:0046324 Regulation of glucose import
Process GO:0046326 Positive regulation of glucose import
Process GO:0046578 Regulation of Ras protein signal transduction
Process GO:0046579 Positive regulation of Ras protein signal transduction
Process GO:0046620 Regulation of organ growth
Process GO:0046622 Positive regulation of organ growth
Process GO:0046885 Regulation of hormone biosynthetic process
Process GO:0046886 Positive regulation of hormone biosynthetic process
Process GO:0046889 Positive regulation of lipid biosynthetic process
Process GO:0046890 Regulation of lipid biosynthetic process
Process GO:0048009 Insulin-like growth factor receptor signaling pathway
Process GO:0048015 Phosphatidylinositol-mediated signaling
Process GO:0048017 Inositol lipid-mediated signaling
Process GO:0048145 Regulation of fibroblast proliferation
Process GO:0048146 Positive regulation of fibroblast proliferation
Process GO:0048286 Lung alveolus development
Process GO:0048468 Cell development
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048589 Developmental growth
Process GO:0048608 Reproductive structure development
Process GO:0048638 Regulation of developmental growth
Process GO:0048639 Positive regulation of developmental growth
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048705 Skeletal system morphogenesis
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048754 Branching morphogenesis of an epithelial tube
Process GO:0048771 Tissue remodeling
Process GO:0048799 Animal organ maturation
Process GO:0048839 Inner ear development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048878 Chemical homeostasis
Process GO:0050650 Chondroitin sulfate proteoglycan biosynthetic process
Process GO:0050654 Chondroitin sulfate proteoglycan metabolic process
Process GO:0050670 Regulation of lymphocyte proliferation
Process GO:0050671 Positive regulation of lymphocyte proliferation
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050708 Regulation of protein secretion
Process GO:0050714 Positive regulation of protein secretion
Process GO:0050727 Regulation of inflammatory response
Process GO:0050728 Negative regulation of inflammatory response
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050732 Negative regulation of peptidyl-tyrosine phosphorylation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050810 Regulation of steroid biosynthetic process
Process GO:0050821 Protein stabilization
Process GO:0050848 Regulation of calcium-mediated signaling
Process GO:0050850 Positive regulation of calcium-mediated signaling
Process GO:0050863 Regulation of T cell activation
Process GO:0050865 Regulation of cell activation
Process GO:0050867 Positive regulation of cell activation
Process GO:0050870 Positive regulation of T cell activation
Process GO:0050877 Nervous system process
Process GO:0050890 Cognition
Process GO:0050896 Response to stimulus
Process GO:0050906 Detection of stimulus involved in sensory perception
Process GO:0050954 Sensory perception of mechanical stimulus
Process GO:0050974 Detection of mechanical stimulus involved in sensory perception
Process GO:0050982 Detection of mechanical stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051056 Regulation of small GTPase mediated signal transduction
Process GO:0051057 Positive regulation of small GTPase mediated signal transduction
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051099 Positive regulation of binding
Process GO:0051101 Regulation of DNA binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051129 Negative regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051146 Striated muscle cell differentiation
Process GO:0051147 Regulation of muscle cell differentiation
Process GO:0051149 Positive regulation of muscle cell differentiation
Process GO:0051153 Regulation of striated muscle cell differentiation
Process GO:0051155 Positive regulation of striated muscle cell differentiation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051222 Positive regulation of protein transport
Process GO:0051223 Regulation of protein transport
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051249 Regulation of lymphocyte activation
Process GO:0051251 Positive regulation of lymphocyte activation
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051450 Myoblast proliferation
Process GO:0051602 Response to electrical stimulus
Process GO:0051606 Detection of stimulus
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051783 Regulation of nuclear division
Process GO:0051785 Positive regulation of nuclear division
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051897 Positive regulation of protein kinase B signaling
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0055001 Muscle cell development
Process GO:0055021 Regulation of cardiac muscle tissue growth
Process GO:0055023 Positive regulation of cardiac muscle tissue growth
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055123 Digestive system development
Process GO:0060251 Regulation of glial cell proliferation
Process GO:0060252 Positive regulation of glial cell proliferation
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060281 Regulation of oocyte development
Process GO:0060283 Negative regulation of oocyte development
Process GO:0060284 Regulation of cell development
Process GO:0060341 Regulation of cellular localization
Process GO:0060348 Bone development
Process GO:0060349 Bone morphogenesis
Process GO:0060363 Cranial suture morphogenesis
Process GO:0060416 Response to growth hormone
Process GO:0060420 Regulation of heart growth
Process GO:0060421 Positive regulation of heart growth
Process GO:0060425 Lung morphogenesis
Process GO:0060426 Lung vasculature development
Process GO:0060428 Lung epithelium development
Process GO:0060429 Epithelium development
Process GO:0060442 Branching involved in prostate gland morphogenesis
Process GO:0060462 Lung lobe development
Process GO:0060463 Lung lobe morphogenesis
Process GO:0060479 Lung cell differentiation
Process GO:0060487 Lung epithelial cell differentiation
Process GO:0060509 Type I pneumocyte differentiation
Process GO:0060510 Type II pneumocyte differentiation
Process GO:0060512 Prostate gland morphogenesis
Process GO:0060525 Prostate glandular acinus development
Process GO:0060526 Prostate glandular acinus morphogenesis
Process GO:0060527 Prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis
Process GO:0060541 Respiratory system development
Process GO:0060548 Negative regulation of cell death
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060736 Prostate gland growth
Process GO:0060740 Prostate gland epithelium morphogenesis
Process GO:0060741 Prostate gland stromal morphogenesis
Process GO:0060765 Regulation of androgen receptor signaling pathway
Process GO:0060766 Negative regulation of androgen receptor signaling pathway
Process GO:0061050 Regulation of cell growth involved in cardiac muscle cell development
Process GO:0061051 Positive regulation of cell growth involved in cardiac muscle cell development
Process GO:0061061 Muscle structure development
Process GO:0061138 Morphogenesis of a branching epithelium
Process GO:0061140 Lung secretory cell differentiation
Process GO:0061448 Connective tissue development
Process GO:0061458 Reproductive system development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070201 Regulation of establishment of protein localization
Process GO:0070371 ERK1 and ERK2 cascade
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070373 Negative regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070663 Regulation of leukocyte proliferation
Process GO:0070665 Positive regulation of leukocyte proliferation
Process GO:0070848 Response to growth factor
Process GO:0070849 Response to epidermal growth factor
Process GO:0070873 Regulation of glycogen metabolic process
Process GO:0070875 Positive regulation of glycogen metabolic process
Process GO:0070884 Regulation of calcineurin-NFAT signaling cascade
Process GO:0070886 Positive regulation of calcineurin-NFAT signaling cascade
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0070977 Bone maturation
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071257 Cellular response to electrical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071316 Cellular response to nicotine
Process GO:0071322 Cellular response to carbohydrate stimulus
Process GO:0071326 Cellular response to monosaccharide stimulus
Process GO:0071331 Cellular response to hexose stimulus
Process GO:0071333 Cellular response to glucose stimulus
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071383 Cellular response to steroid hormone stimulus
Process GO:0071384 Cellular response to corticosteroid stimulus
Process GO:0071385 Cellular response to glucocorticoid stimulus
Process GO:0071392 Cellular response to estradiol stimulus
Process GO:0071393 Cellular response to progesterone stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071548 Response to dexamethasone
Process GO:0071549 Cellular response to dexamethasone stimulus
Process GO:0071695 Anatomical structure maturation
Process GO:0071704 Organic substance metabolic process
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080164 Regulation of nitric oxide metabolic process
Process GO:0090030 Regulation of steroid hormone biosynthetic process
Process GO:0090031 Positive regulation of steroid hormone biosynthetic process
Process GO:0090068 Positive regulation of cell cycle process
Process GO:0090199 Regulation of release of cytochrome c from mitochondria
Process GO:0090201 Negative regulation of release of cytochrome c from mitochondria
Process GO:0090257 Regulation of muscle system process
Process GO:0097066 Response to thyroid hormone
Process GO:0097094 Craniofacial suture morphogenesis
Process GO:0097190 Apoptotic signaling pathway
Process GO:0097191 Extrinsic apoptotic signaling pathway
Process GO:0097192 Extrinsic apoptotic signaling pathway in absence of ligand
Process GO:0097305 Response to alcohol
Process GO:0098727 Maintenance of cell number
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0106056 Regulation of calcineurin-mediated signaling
Process GO:0106058 Positive regulation of calcineurin-mediated signaling
Process GO:0110148 Biomineralization
Process GO:0150077 Regulation of neuroinflammatory response
Process GO:0150079 Negative regulation of neuroinflammatory response
Process GO:1900141 Regulation of oligodendrocyte apoptotic process
Process GO:1900142 Negative regulation of oligodendrocyte apoptotic process
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901135 Carbohydrate derivative metabolic process
Process GO:1901137 Carbohydrate derivative biosynthetic process
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901566 Organonitrogen compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901654 Response to ketone
Process GO:1901655 Cellular response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902003 Regulation of amyloid-beta formation
Process GO:1902430 Negative regulation of amyloid-beta formation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902991 Regulation of amyloid precursor protein catabolic process
Process GO:1902992 Negative regulation of amyloid precursor protein catabolic process
Process GO:1903018 Regulation of glycoprotein metabolic process
Process GO:1903020 Positive regulation of glycoprotein metabolic process
Process GO:1903037 Regulation of leukocyte cell-cell adhesion
Process GO:1903039 Positive regulation of leukocyte cell-cell adhesion
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903556 Negative regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903578 Regulation of ATP metabolic process
Process GO:1903580 Positive regulation of ATP metabolic process
Process GO:1903829 Positive regulation of protein localization
Process GO:1904016 Response to Thyroglobulin triiodothyronine
Process GO:1904017 Cellular response to Thyroglobulin triiodothyronine
Process GO:1904035 Regulation of epithelial cell apoptotic process
Process GO:1904036 Negative regulation of epithelial cell apoptotic process
Process GO:1904073 Regulation of trophectodermal cell proliferation
Process GO:1904075 Positive regulation of trophectodermal cell proliferation
Process GO:1904192 Regulation of cholangiocyte apoptotic process
Process GO:1904193 Negative regulation of cholangiocyte apoptotic process
Process GO:1904645 Response to amyloid-beta
Process GO:1904646 Cellular response to amyloid-beta
Process GO:1904705 Regulation of vascular associated smooth muscle cell proliferation
Process GO:1904707 Positive regulation of vascular associated smooth muscle cell proliferation
Process GO:1904888 Cranial skeletal system development
Process GO:1904951 Positive regulation of establishment of protein localization
Process GO:1905459 Regulation of vascular associated smooth muscle cell apoptotic process
Process GO:1905460 Negative regulation of vascular associated smooth muscle cell apoptotic process
Process GO:1905562 Regulation of vascular endothelial cell proliferation
Process GO:1905564 Positive regulation of vascular endothelial cell proliferation
Process GO:1905879 Regulation of oogenesis
Process GO:1990314 Cellular response to insulin-like growth factor stimulus
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000112 Regulation of cellular macromolecule biosynthetic process
Process GO:2000116 Regulation of cysteine-type endopeptidase activity
Process GO:2000117 Negative regulation of cysteine-type endopeptidase activity
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000177 Regulation of neural precursor cell proliferation
Process GO:2000179 Positive regulation of neural precursor cell proliferation
Process GO:2000241 Regulation of reproductive process
Process GO:2000242 Negative regulation of reproductive process
Process GO:2000288 Positive regulation of myoblast proliferation
Process GO:2000291 Regulation of myoblast proliferation
Process GO:2000677 Regulation of transcription regulatory region DNA binding
Process GO:2000679 Positive regulation of transcription regulatory region DNA binding
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001233 Regulation of apoptotic signaling pathway
Process GO:2001234 Negative regulation of apoptotic signaling pathway
Process GO:2001236 Regulation of extrinsic apoptotic signaling pathway
Process GO:2001237 Negative regulation of extrinsic apoptotic signaling pathway
Component GO:0005576 Extracellular region
Component GO:0005614 Interstitial matrix
Component GO:0005615 Extracellular space
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005886 Plasma membrane
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0016942 Insulin-like growth factor binding protein complex
Component GO:0030133 Transport vesicle
Component GO:0030141 Secretory granule
Component GO:0030312 External encapsulating structure
Component GO:0031012 Extracellular matrix
Component GO:0031091 Platelet alpha granule
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031982 Vesicle
Component GO:0032991 Protein-containing complex
Component GO:0035867 alphav-beta3 integrin-IGF-1-IGF1R complex
Component GO:0036454 Growth factor complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042567 Insulin-like growth factor ternary complex
Component GO:0043025 Neuronal cell body
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0044297 Cell body
Component GO:0062023 Collagen-containing extracellular matrix
Component GO:0070382 Exocytic vesicle
Component GO:0071944 Cell periphery
Component GO:0097708 Intracellular vesicle
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0099503 Secretory vesicle
Component GO:0110165 Cellular anatomical entity
Function GO:0005102 Signaling receptor binding
Function GO:0005158 Insulin receptor binding
Function GO:0005159 Insulin-like growth factor receptor binding
Function GO:0005178 Integrin binding
Function GO:0005179 Hormone activity
Function GO:0005488 Binding
Function GO:0005496 Steroid binding
Function GO:0005515 Protein binding
Function GO:0008047 Enzyme activator activity
Function GO:0008083 Growth factor activity
Function GO:0008289 Lipid binding
Function GO:0019207 Kinase regulator activity
Function GO:0019209 Kinase activator activity
Function GO:0019887 Protein kinase regulator activity
Function GO:0030234 Enzyme regulator activity
Function GO:0030295 Protein kinase activator activity
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0043539 Protein serine/threonine kinase activator activity
Function GO:0044877 Protein-containing complex binding
Function GO:0048018 Receptor ligand activity
Function GO:0050839 Cell adhesion molecule binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-114608 Platelet degranulation
RCTM RNO-162582 Signal Transduction
RCTM RNO-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
RCTM RNO-2428924 IGF1R signaling cascade
RCTM RNO-2428928 IRS-related events triggered by IGF1R
RCTM RNO-2428933 SHC-related events triggered by IGF1R
RCTM RNO-2980736 Peptide hormone metabolism
RCTM RNO-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-422085 Synthesis, secretion, and deacylation of Ghrelin
RCTM RNO-76002 Platelet activation, signaling and aggregation
RCTM RNO-76005 Response to elevated platelet cytosolic Ca2+
RCTM RNO-9006934 Signaling by Receptor Tyrosine Kinases
WikiPathways WP1290 Apoptosis
WikiPathways WP155 Adipogenesis
WikiPathways WP188 Focal adhesion
WikiPathways WP397 ID signaling pathway
WikiPathways WP5057 Burn wound healing
WikiPathways WP655 p53 pathway
WikiPathways WP656 p53 signal pathway
KEGG rno01521 EGFR tyrosine kinase inhibitor resistance
KEGG rno01522 Endocrine resistance
KEGG rno04010 MAPK signaling pathway
KEGG rno04014 Ras signaling pathway
KEGG rno04015 Rap1 signaling pathway
KEGG rno04066 HIF-1 signaling pathway
KEGG rno04068 FoxO signaling pathway
KEGG rno04114 Oocyte meiosis
KEGG rno04115 p53 signaling pathway
KEGG rno04150 mTOR signaling pathway
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04152 AMPK signaling pathway
KEGG rno04211 Longevity regulating pathway
KEGG rno04213 Longevity regulating pathway - multiple species
KEGG rno04510 Focal adhesion
KEGG rno04550 Signaling pathways regulating pluripotency of stem cells
KEGG rno04730 Long-term depression
KEGG rno04750 Inflammatory mediator regulation of TRP channels
KEGG rno04913 Ovarian steroidogenesis
KEGG rno04914 Progesterone-mediated oocyte maturation
KEGG rno04935 Growth hormone synthesis, secretion and action
KEGG rno04960 Aldosterone-regulated sodium reabsorption
KEGG rno05200 Pathways in cancer
KEGG rno05202 Transcriptional misregulation in cancer
KEGG rno05205 Proteoglycans in cancer
KEGG rno05214 Glioma
KEGG rno05215 Prostate cancer
KEGG rno05218 Melanoma
KEGG rno05224 Breast cancer
KEGG rno05410 Hypertrophic cardiomyopathy
KEGG rno05414 Dilated cardiomyopathy

Expression profile of Igf1 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 11.7500545
GSM2685202 MX2 tissue: Myocardium gender: female 12.1993765
GSM2685203 MX3 tissue: Myocardium gender: female 11.5559005
GSM2685204 MX4 tissue: Myocardium gender: male 12.4054195
GSM2685205 DZ1 tissue: Myocardium gender: male 12.037385
GSM2685206 DZ2 tissue: Myocardium gender: male 12.364095500000001
GSM2685207 DZ3 tissue: Myocardium gender: female 11.556299500000002
GSM2685208 DZ4 tissue: Myocardium gender: female 11.4989825
GSM2685209 JJ1 tissue: Myocardium gender: male 11.4852985
GSM2685210 JJ2 tissue: Myocardium gender: female 11.369095999999999
GSM2685211 JJ3 tissue: Myocardium gender: female 11.4383915
GSM2685212 JJ4 tissue: Myocardium gender: male 11.78061
GSM2685213 NG1 tissue: Myocardium gender: male 11.774871
GSM2685214 NG2 tissue: Myocardium gender: female 11.108402
GSM2685215 NG3 tissue: Myocardium gender: male 11.845611
GSM2685216 NG4 tissue: Myocardium gender: female 11.723624000000001
GSM2685217 YL1 tissue: Myocardium gender: male 11.980037
GSM2685218 YL2 tissue: Myocardium gender: male 11.7151585
GSM2685219 YL3 tissue: Myocardium gender: female 11.8350995
GSM2685220 YL4 tissue: Myocardium gender: female 11.957928500000001
GSM2685221 QC1 tissue: Myocardium gender: male 12.265439
GSM2685222 QC2 tissue: Myocardium gender: male 12.427574
GSM2685223 QC3 tissue: Myocardium gender: female 11.859254
GSM2685224 QC4 tissue: Myocardium gender: female 11.6108055

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.619239016
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.051459372
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.141051901
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.991112016
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.421102264
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.342333229

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 10942.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 8402.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 13145.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 12443.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 10475.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 10337.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 10885.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 24132.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 10111.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 13506.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 10205.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 18094.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 7974.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 9609.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 9145.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 12013.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.895896
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.834562
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.774928
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.893223
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.824193
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.828288

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.936
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 18.973
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 14.581
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 6.437
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 6.854

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.780295055
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.636391886
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.412723174

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 242.24
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 175.0
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 179.94
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 211.56
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 172.44
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 171.2
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 232.38000000000002
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 177.85999999999999
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 212.71999999999997
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 251.06
GSM27494 CTL_a (control, 1st replicate) 174.18
GSM27495 CTL_b (control, 2nd replicate) 155.54
GSM27496 CTL_c (control, 3rd replicate) 285.82
GSM27497 CTL_d (control, 4th replicate) 174.86
GSM27498 CTL_e (control, 5th replicate) 200.1
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 171.2
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 178.78
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 165.01999999999998
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 127.44000000000001
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 320.58000000000004
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 312.71999999999997
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 253.5
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 166.21999999999997
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 245.71999999999997
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 438.23999999999995
GSM27509 ISCH_a (ischemia, 1st replicate) 326.2
GSM27510 ISCH_b (ischemia, 2nd replicate) 227.74
GSM27511 ISCH_c (ischemia, 3rd replicate) 303.28000000000003
GSM27512 ISCH_d (ischemia, 4th replicate) 289.58000000000004
GSM27513 ISCH_e (ischemia, 5th replicate) 315.38

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 151.3
GSM30791 baseline control 02 male, 275-300g 104.7
GSM30792 baseline control 03 male, 275-300g 130.3
GSM30793 baseline control 04 male, 275-300g 155.7
GSM30794 baseline control 05 male, 275-300g 133.8
GSM30795 baseline control 06 male, 275-300g 38.1
GSM30796 baseline control 07 male, 275-300g 138.7
GSM30797 baseline control 08 male, 275-300g 36.8
GSM30798 baseline control 09 male, 275-300g 244.0
GSM30799 pain 01 193.3
GSM30800 pain 02 156.4
GSM30801 pain 03 239.9
GSM30802 pain 04 26.1
GSM30803 pain 05 277.8
GSM30804 FC 01 188.2
GSM30805 FC 02 269.8
GSM30806 FC 03 288.2
GSM30807 FC 04 95.7
GSM30808 FC 05 231.5
GSM30809 IFC 01 139.4
GSM30810 IFC 02 114.3
GSM30811 IFC 03 102.1
GSM30812 IFC 04 39.2
GSM30813 IFC 05 263.8
GSM99800 isoflurane 01 male, 275-300g 136.6
GSM99801 isoflurane 02 male, 275-300g 173.5
GSM99802 isoflurane 03 male, 275-300g 30.9
GSM99803 isoflurane 04 male, 275-300g 126.1
GSM99804 isoflurane 05 male, 275-300g 252.0

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 730.151
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 651.8575
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 584.3034
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 420.1287
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 218.1992
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 276.3413
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 261.5082
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 348.1322
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 1197.1992

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 5.63792
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 6.27283
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 7.21298
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 8.60269
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 5.63553
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 6.52384
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 8.93651
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 8.52904
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 5.091
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 5.09798
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 7.62781
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 7.27122
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 6.22986
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 5.71542
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 8.11729
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 8.16118

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.58017
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.73918
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.63835
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.66516
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.37323
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.26739
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.16225
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.39304
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.32899
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.27838
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.55738
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.68176
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.84009
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.531
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.8242
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.4348
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.97308
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.66489
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.9002
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.8757
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 13.13841
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.90335
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 13.03251
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.99598
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.93904
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.37078
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.408
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.12993
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.47833
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.16071
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 12.24782
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.97383
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 12.44017
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 12.06511
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 12.32174
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.81262
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.56873
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.66954
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 12.25265
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.82352
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.24766
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.34204
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.09815
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.12539
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.12722

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 34.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 47.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 40.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 30.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 36.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 25.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 48.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 27.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 32.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 40.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 31.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 36.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 40.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 42.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 20.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 30.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 24.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 32.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 25.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 24.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 56.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 48.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 31.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 20.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 34.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 19.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 47.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 43.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 41.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 30.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 35.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 50.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 37.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 26.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 28.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 15.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 932.14032
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 774.246033
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 1190.5177
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 1010.192139

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0146
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0928
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.044
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.0728
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.0467
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.0193
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0465
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0411
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0489
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.109
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.0913
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.122

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 33.4
GSM5121 Isoflurane single exposure control-2 21.6
GSM5122 Isoflurane single exposure control-3 47.1
GSM5124 Isoflurane single exposure 1 hr-1 35.92
GSM5126 Isoflurane single exposure 1 hr-2 35.019999999999996
GSM5127 Isoflurane single exposure 2 hr-1 21.98
GSM5130 Isoflurane single exposure 2 hr-2 109.58
GSM5131 Isoflurane single exposure 2 hr-3 34.2

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.119216557
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.794444828
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.082073147
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.849259159
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.555794851
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.942960594
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.114632252
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.481289778
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.849259159
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.076947481
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.953597669
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.728471173
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.821671303
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.715990332
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.653293002
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.622991045
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.803831688
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.657168375
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.985071607
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.820604647
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.791440603
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.80921573
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.949006127
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.70874687

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 7.891646896
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 51.0224303
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 29.33405427
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 5.783624475
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 4.53801828
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 25.9697677
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 55.52200978
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 6.14165081
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 38.03096905
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 11.98296945
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.832088245
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 25.56837381
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 25.41201701
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 55.17667877

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.119216557
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.794444828
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.082073147
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.849259159
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.555794851
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.942960594
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.114632252
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.481289778
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.849259159
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.076947481
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.953597669
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.728471173
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.821671303
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.715990332
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.653293002
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.622991045
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.803831688
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.657168375
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.985071607
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.820604647
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.791440603
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.80921573
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.949006127
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.70874687
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 7.891646896
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 51.0224303
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 29.33405427
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 5.783624475
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 4.53801828
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 25.9697677
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 55.52200978
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 6.14165081
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 38.03096905
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 11.98296945
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.832088245
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 25.56837381
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 25.41201701
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 55.17667877

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 36.82000000000001
GSM5084 Control 2 55.96
GSM5085 Control 3 41.48
GSM5086 Control 4 64.74
GSM5087 Control 5 47.379999999999995
GSM5090 Control 6 54.44
GSM5105 Control 7 42.2
GSM5106 Control 8 40.64
GSM5107 Control 9 46.1
GSM5108 Halothane 10 exposure-1 34.14
GSM5109 Halothane 10 exposures-2 38.22
GSM5110 Halothane 10 exposures-3 44.86
GSM5111 Halothane 5 exposures-1 45.08
GSM5112 Halothane 5 exposures-2 57.040000000000006
GSM5113 Halothane 5 exposures-3 51.14
GSM5114 Isoflurane 10 exposures-1 48.67999999999999
GSM5115 Isoflurane 10 exposures-2 55.7
GSM5116 Isoflurane 10 exposures-3 35.32
GSM5117 Isoflurane 5 exposures-1 49.44
GSM5118 Isoflurane 5 exposures-2 42.86
GSM5119 Isoflurane 5 exposures-3 61.0
GSM11379 Control 10 31.7
GSM11380 Control 11 57.2
GSM11381 Control 12 58.42

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 398.737
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 519.183